Introduction to Diseases Associated with Kaposi’s Sarcoma-Associated Herpesvirus



Primary Effusion Lymphoma Representational Difference Analysis KSHV Infection Primary Effusion Lymphoma Cell KSHV Genome 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


  1. Adams, V., Kempf, W., Schmid, M., Müller, B., Briner, J. and Burg, G. (1995) Absence of herpesvirus-like DNA sequences in skin cancers of non-immunosuppressed patients. Lancet. 346, 1715.PubMedGoogle Scholar
  2. Altschul, S. F., Gish, W., Miller, W., Myers, E. W. and Lipman, D. J. (1990) Basic local alignment search tool. J Mol Biol. 215, 403–410.PubMedGoogle Scholar
  3. Ambinder, R. F., Newman, C., Hayward, G. S., Biggar, R., Melbye, M., Kestens, L., Van Marck, E., Piot, P., Gigase, P. and Wright, P. B. (1985) Lack of association of cytomegalovirus with endemic African Kaposi's sarcoma. J Infect Dis. 156, 133.Google Scholar
  4. Ambroziak, J. A., Blackbourn, D. J., Herndier, B. G., Glogau, R. G., Gullett, J. H., McDonald, A. R., Lennette, E. T. and Levy, J. A. (1995) Herpes-like sequences in HIV-infected and uninfected Kaposi's sarcoma patients. Science. 268, 582–583.PubMedGoogle Scholar
  5. Arvanitakis, L., Mesri, E. A., Nador, R. G., Said, J. W., Asch, A. S., Knowles, D. M. and Cesarman, E. (1996) Establishment and characterization of a primary effusion (body cavity-based) lymphoma cell line (BC-3) harboring kaposi's sarcoma-associated herpesvirus (KSHV/HHV-8) in the absence of Epstein-Barr virus. Blood. 88, 2648–2654.PubMedGoogle Scholar
  6. Athale, U. M., Patil, P. S., Chintu, C. and Elem, B. (1995) Influence of HIV Epidemic on the Incidence of Kaposi's Sarcoma in Zambian Children. J AIDS and Hum Retro. 8, 96–100.Google Scholar
  7. Barozzi, P., Luppi, M., Facchetti, F., Mecucci, C., Alu, M., Sarid, R., Rasini, V., Ravazzini, L., Rossi, E., Festa, S., Crescenzi, B., Wolf, D. G., Schulz, T. F. and Torelli, G. (2003) Post-transplant Kaposi sarcoma originates from the seeding of donor-derived progenitors. Nat Med. 9, 554–561.PubMedGoogle Scholar
  8. Bassett, M. T., Chokunonga, E., Mauchaza, B., Levy, L., Ferlay, J. and Parkin, D. M. (1995) Cancer in the African population of Harare, Zimbabwe, 1990–1992. Internatl J Cancer. 63, 29–36.Google Scholar
  9. Beck, J. T., Hsu, S. M., Wijdenes, J., Bataille, R., Klein, B., Vesole, D., Hayden, K., Jagannath, S. and Barlogie, B. (1994) Brief report: alleviation of systemic manifestations of Castleman's disease by monoclonal anti-interleukin-6 antibody. New Engl J Med. 330, 602–605.PubMedGoogle Scholar
  10. Beral, V., Peterman, T. A., Berkelman, R. L. and Jaffe, H. W. (1990) Kaposi's sarcoma among persons with AIDS: a sexually transmitted infection? Lancet. 335, 123–128.PubMedGoogle Scholar
  11. Biggar, R. J., Whitby, D., Marshall, V., Linhares, A. C. and Black, F. (2000) Human herpesvirus 8 in Brazilian Amerindians: a hyperendemic population with a new subtype. J Infect Dis. 181, 1562–1568.PubMedGoogle Scholar
  12. Boshoff, C., Gao, S. J., Healy, L. E., Matthews, S., Thomas, A. J., Coignet, L., Warnke, R. A., Strauchen, J. A., Matutes, E., Kamel, O. W., Moore, P. S., Weiss, R. A. and Chang, Y. (1998) Establishing a KSHV+ cell line (BCP-1) from peripheral blood and characterizing its growth in Nod/SCID mice. Blood. 91, 1671–1679.PubMedGoogle Scholar
  13. Boshoff, C., Schulz, T. F., Kennedy, M. M., Graham, A. K., Fisher, C., Thomas, A., McGee, J. O., Weiss, R. A. and O'Leary, J. J. (1995) Kaposi's sarcoma-associated herpesvirus infects endothelial and spindle cells. Nat Med. 1, 1274–1278.PubMedGoogle Scholar
  14. Boshoff, C., Talbot, S., Kennedy, M., O'Leary, J., Schulz, T. and Chang, Y. (1996) HHV8 and skin cancers in immunosuppressed patients [letter] [published erratum appears in Lancet 1996 Jul 13; 348(9020):138]. Lancet. 347, 338–339.PubMedGoogle Scholar
  15. Boshoff, C., Whitby, D., Hatziionnou, T., Fisher, C., van der Walt, J., Hatzakis, A., Weiss, R. and Schulz, T. (1995) Kaposi's sarcoma-associated herpesvirus in HIV-negative Kaposi's sarcoma. Lancet. 345, 1043–1044.PubMedGoogle Scholar
  16. Brandt, S. J., Bodine, D. M., Dunbar, C. E. and Nienhuis, A. W. (1990) Dysregulated interleukin 6 expression produces a syndrome resembling Castleman's disease in mice. J Clin Invest. 86, 592–599.PubMedGoogle Scholar
  17. Breimer, L. H. (1984) Did Moriz Kaposi describe AIDS in 1872?Clin Med. 19, 156–158.Google Scholar
  18. Casper, C., Nichols, W. G., Huang, M. L., Corey, L. and Wald, A. (2004) Remission of HHV-8 and HIV-associated multicentric Castleman disease with ganciclovir treatment. Blood. 103, 1632–1634.PubMedGoogle Scholar
  19. Castleman, B., Iverson, L. and Menendez, V. P. (1956) Localized mediastinal lymph node hyperplasia resembling thymoma. Cancer. 9, 822.Google Scholar
  20. Cesarman, E., Chang, Y., Moore, P. S., Said, J. W. and Knowles, D. M. (1995) Kaposi's sarcoma-associated herpesvirus-like DNA sequences in AIDS-related body-cavity-based lymphomas. N Engl J Med. 332, 1186–1191.PubMedGoogle Scholar
  21. Cesarman, E., Moore, P. S., Rao, P. H., Inghirami, G., Knowles, D. M. and Chang, Y. (1995) In vitro establishment and characterization of two acquired immunodeficiency syndrome-related lymphoma cell lines (BC-1 and BC-2) containing Kaposi's sarcoma-associated herpesvirus-like (KSHV) DNA sequences. Blood. 86, 2708–2714.PubMedGoogle Scholar
  22. Chang, Y., Cesarman, E., Pessin, M. S., Lee, F., Culpepper, J., Knowles, D. M. and Moore, P. S. (1994) Identification of herpesvirus-like DNA sequences in AIDS-associated Kaposi's sarcoma. Science. 265, 1865–1869.Google Scholar
  23. Chang, Y., Ziegler, J. L., Wabinga, H., Katongole-Mbidde, E., Boshoff, C., Whitby, D., Schulz, T., Weiss, R. A., Jaffe, H. A., Group, U. K. s. S. S. and Moore, P. S. (1996) Kaposi's sarcoma-associated herpesvirus and Kaposi's sarcoma in Africa. Archiv Int Med. 156, 202–204.Google Scholar
  24. Chen, K. T. (1984) Multicentric Castleman's disease and Kaposi's sarcoma. Am J Surg Pathol. 8, 287–293.PubMedGoogle Scholar
  25. Chow, D.-c., He, X.-l., Snow, A. L., Rose-John, S. and Garcia, K. C. (2001) Structure of an extracellular gp130 cytokine receptor signaling complex. Science. 291, 2150–2155.PubMedGoogle Scholar
  26. Collandre, H., Ferris, S., Grau, O., Montagnier, L. and Blanchard, A. (1995) Kaposi's sarcoma and new herpesvirus. Lancet. 345, 1043.PubMedGoogle Scholar
  27. Collins, L. S., Fowler, A., Tong, C. Y. and de Ruiter, A. (2006) Multicentric Castleman's disease in HIV infection. Int J STD AIDS. 17, 19–24; quiz 25.PubMedGoogle Scholar
  28. Cook-Mozaffari, P., Newton, R., Beral, V. and Burkitt, D. P. (1998) The geographical distribution of Kaposi's sarcoma and of lymphomas in Africa before the AIDS epidemic. Br J Cancer. 78, 1521–1528.PubMedGoogle Scholar
  29. Dagna, L., Broccolo, F., Paties, C. T., Ferrarini, M., Sarmati, L., Praderio, L., Sabbadini, M. G., Lusso, P. and Malnati, M. S. (2005) A relapsing inflammatory syndrome and active human herpesvirus 8 infection. N Engl J Med. 353, 156–163.PubMedGoogle Scholar
  30. Davies, J. N. and Lothe, F. (1962) Kaposi's sarcoma in African children. Acta Unio Int Contra Cancrum. 18, 394–399.PubMedGoogle Scholar
  31. De Benedetti, F., Pignatti, P., Vivarelli, M., Meazza, C., Ciliberto, G., Savino, R. and Martini, A. (2001) In vivo neutralization of human IL-6 (hIL-6) achieved by immunization of hIL-6-transgenic mice with a hIL-6 receptor antagonist. J Immunol. 166, 4334–4340.PubMedGoogle Scholar
  32. De Lellis, L., Fabris, M., Cassai, E., Corallini, A., Giraldo, G., Feo, C. and Monini, P. (1995) Herpesvirus-like DNA sequences in non-AIDS Kaposi's sarcoma. J Infect Dis. 172, 1605–1607.PubMedGoogle Scholar
  33. De Rosa, G., Barra, E., Guarino, M. and Gentile, R. (1989) Multicentric Castleman's disease in association with Kaposi's sarcoma. Appl Pathol. 7, 105–110.PubMedGoogle Scholar
  34. Desrosiers, R. C., Sasseville, V. G., Czajak, S. C., Zhang, X., Mansfield, K. G., Kaur, A., Johnson, R. P., Lackner, A. A. and Jung, J. U. (1997) A herpesvirus of rhesus monkeys related to the human Kaposi sarcoma-associated herpesvirus. J Virol. 71, 9764–9769.PubMedGoogle Scholar
  35. Dickson, D., Ben-Ezra, J. M., Reed, J., Flax, H. and Janis, R. (1985) Multicentric giant lymph node hyperplasia, Kaposi's sarcoma, and lymphoma. Arch Pathol Lab Med. 109, 1013–1018.PubMedGoogle Scholar
  36. Dorfman, R. F. (1988) Kaposi's sarcoma: evidence supporting its origin from the lymphatic system. Lymphology. 21, 45–52.PubMedGoogle Scholar
  37. Du, M. Q., Diss, T. C., Liu, H., Ye, H., Hamoudi, R. A., Cabecadas, J., Dong, H. Y., Harris, N. L., Chan, J. K., Rees, J. W., Dogan, A. and Isaacson, P. G. (2002) KSHV- and EBV-associated germinotropic lymphoproliferative disorder. Blood. 100, 3415–3418.PubMedGoogle Scholar
  38. Du, M. Q., Liu, H., Diss, T. C., Ye, H., Hamoudi, R. A., Dupin, N., Meignin, V., Oksenhendler, E., Boshoff, C. and Isaacson, P. G. (2001) Kaposi sarcoma-associated herpesvirus infects monotypic (IgMlambda) but polyclonal naive B cells in Castleman disease and associated lymphoproliferative disorders. Blood. 97, 2130–2136.PubMedGoogle Scholar
  39. Dupin, N., Diss, T. L., Kellam, P., Tulliez, M., Du, M. Q., Sicard, D., Weiss, R. A., Isaacson, P. G. and Boshoff, C. (2000) HHV-8 is associated with a plasmablastic variant of Castleman disease that is linked to HHV-8-positive plasmablastic lymphoma. Blood. 95, 1406–1412.PubMedGoogle Scholar
  40. Dupin, N., Grandadam, M., Calvez, V., Gorin, I., Aubin, J. T., Harvard, S., Lamy, F., Leibowitch, M., Huraux, J. M., Escande, J. P. and Agut, H. (1995) Herpesvirus-like DNA in patients with Mediterranean Kaposi's sarcoma. Lancet. 345, 761–762.PubMedGoogle Scholar
  41. Eltom, M. A., Jemal, A., Mbulaiteye, S. M., Devesa, S. S. and Biggar, R. J. (2002) Trends in Kaposi's sarcoma and non-Hodgkin's lymphoma incidence in the United States from 1973 through 1998. J Natl Cancer Inst. 94, 1204–1210.PubMedGoogle Scholar
  42. Ensoli, B., Barillari, G. and Gallo, R. C. (1992) Cytokines and growth factors in the pathogenesis of AIDS-associated Kaposi's sarcoma. Immunol Rev. 127, 147–155.PubMedGoogle Scholar
  43. Ensoli, B., Barillari, G., Salahuddin, S. Z., Gallo, R. C. and Wong, S. F. (1990) Tat protein of HIV-1 stimulates growth of cells derived from Kaposi's sarcoma lesions of AIDS patients. Nature. 345, 84–86.PubMedGoogle Scholar
  44. Eto, H., Kamidigo, N. O., Murakami, M. K., Nakamura, S., Toriyama, K. and Itakura, H. (1996) Short report: herpes-like DNA sequences in African-endemic and acquired immunodeficiency syndrome-associated Kaposi's sarcoma. Am J Trop Med Hyg. 55, 405–406.PubMedGoogle Scholar
  45. Fan, W., Bubman, D., Chadburn, A., Harrington, W. J., Jr., Cesarman, E. and Knowles, D. M. (2005) Distinct subsets of primary effusion lymphoma can be identified based on their cellular gene expression profile and viral association. J Virol. 79, 1244–1251.PubMedGoogle Scholar
  46. Flamand, L., Zeman, R. A., Bryant, J. L., Lunardi, I. Y. and Gallo, R. C. (1996) Absence of human herpesvirus 8 DNA sequences in neoplastic Kaposi's sarcoma cell lines. J Acquir Immune Defic Syndr Hum Retrovirol. 13, 194–197.PubMedGoogle Scholar
  47. Foreman, K. E., Friborg, J. J., Kong, W. P., Woffendin, C., Polverini, P. J., Nickoloff, B. J. and Nabel, G. J. (1997) Propagation of a human herpesvirus from AIDS-associated Kaposi's sarcoma. New Engl J Med. 336, 163–171.PubMedGoogle Scholar
  48. Frizzera, G. (1988) Castleman's disease and related disorders. Semin Diagn Pathol. 5, 346–364.PubMedGoogle Scholar
  49. Frizzera, G., Banks, P. M., Massarelli, G. and Rosai, J. (1983) A systemic lymphoproliferative disorder with morphologic features of Castleman's disease. Pathological findings in 15 patients. Am J Surg Pathol. 7, 211–231.Google Scholar
  50. Frizzera, G., Peterson, B. A., Bayrd, E. D. and Goldman, A. (1985) A systemic lymphoproliferative disorder with morphologic features of Castleman's disease: clinical findings and clinicopathologic correlations in 15 patients. J Clin Oncol. 3, 1202–1216.PubMedGoogle Scholar
  51. Gaidano, G., Capello, D., Cilia, A. M., Gloghini, A., Perin, T., Quattrone, S., Migliazza, A., Lo Coco, F., Saglio, G., Ascoli, V. and Carbone, A. (1999) Genetic characterization of HHV-8/KSHV-positive primary effusion lymphoma reveals frequent mutations of BCL6: implications for disease pathogenesis and histogenesis. Genes Chromosomes Cancer. 24, 16–23.PubMedGoogle Scholar
  52. Gao, S.-J., Kingsley, L., Hoover, D. R., Spira, T. J., Rinaldo, C. R., Saah, A., Phair, J., Detels, R., Parry, P., Chang, Y. and Moore, P. S. (1996) Seroconversion to antibodies against Kaposi's sarcoma-associated herpesvirus-related latent nuclear antigens before the development of Kaposi's sarcoma. New Engl J Med. 335, 233–241.PubMedGoogle Scholar
  53. Gao, S. J., Kingsley, L., Li, M., Zheng, W., Parravicini, C., Ziegler, J., Newton, R., Rinaldo, C. R., Saah, A., Phair, J., Detels, R., Chang, Y. and Moore, P. S. (1996) KSHV antibodies among Americans, Italians and Ugandans with and without Kaposi's sarcoma. Nat Med. 2, 925–928.PubMedGoogle Scholar
  54. Giraldo, G., Beth, E. and Haguenau, F. (1972) Herpes-type particles in tissue culture of Kaposi's sarcoma from different geographic regions. J Natl Cancer Inst. 49, 1509.PubMedGoogle Scholar
  55. Giraldo, G., Kourilsky, F. M., Henle, W., Mike, V., Huraux, J. M., Andersen, H. K., Gharbi, M. R., Kyalwazi, S. K. and Puissant, A. (1975) Antibody patterns to herpesviruses in Kaposi's sarcoma: serological association of European Kaposi's sarcoma with cytomegalovirus. Int J Cancer. 15, 839–848.PubMedGoogle Scholar
  56. Harwood, A. R., Osoba, D. and Hofstader, S. L. (1979) Kaposi's sarcoma in recipients of renal transplants. Am J Med. 67, 759–765.PubMedGoogle Scholar
  57. Haverkos, H. W. and Curran, J. W. (1982) The current outbreak of Kaposi's sarcoma and opportunistic infections. CA Cancer J Clin. 32, 330–339.PubMedGoogle Scholar
  58. Haverkos, H. W., Kopstein, A. N., Wilson, H. and Drotman, P. (1994) Nitrite inhalants: history, epidemiology, and possible links to AIDS. Environ Health Perspect. 102, 858–861.PubMedGoogle Scholar
  59. Hayward, G. S. (1999) KSHV strains: the origins and global spread of the virus. Semin Cancer Biol. 9, 187–199.PubMedGoogle Scholar
  60. Hill, A. B. (1965) Environment and disease: association or causation ? Proc R Soc Med. 58, 295–300.Google Scholar
  61. Hladik, W., Dollard, S. C., Mermin, J., Fowlkes, A. L., Downing, R., Amin, M. M., Banage, F., Nzaro, E., Kataaha, P., Dondero, T. J., Pellett, P. E. and Lackritz, E. M. (2006) Transmission of human herpesvirus 8 by blood transfusion. N Engl J Med. 355, 1331–1338.PubMedGoogle Scholar
  62. Hocqueloux, L., Agbalika, F., Oksenhendler, E. and Molina, J. M. (2001) Long-term remission of an AIDS-related primary effusion lymphoma with antiviral therapy. Aids. 15, 280–282.PubMedGoogle Scholar
  63. Holubar, K. and Fatovic-Ferencic, S. (2001) 2002, a hundred years after Kaposi – a post-holocaust coup d'oeuil of Vienna's Jewish heritage in dermatology. J Invest Dermatol. 117, 1329–1330.PubMedGoogle Scholar
  64. Holubar, K. and Frankl, J. (1981) Moriz (Kohn) Kaposi. Am J Dermatopathol. 3, 349–354.PubMedGoogle Scholar
  65. IARC Working Group (1997) Proceedings of the IARC Working Group on the Evaluation of Carcinogenic Risks to Humans. Epstein-Barr Virus and Kaposi's Sarcoma Herpesvirus/Human Herpesvirus 8. Lyon, France, 17–24 June 1997. IARC Monogr Eval Carcinog Risks Hum. 70, 1–492.Google Scholar
  66. International Collaboration on HIV and Cancer (2000) Highly active antiretroviral therapy and incidence of cancer in human immunodeficiency virus-infected adults. J Natl Cancer Inst. 92, 1823–1830.Google Scholar
  67. Jaffe, H. W., Choi, K., Thomas, P. A. and et al. (1983) National case-control study of Kaposi's sarcoma and pneumocystis carinii pneumonia in homosexual men. I. Epidemiologic results. Ann Intern Med. 99, 145–151.Google Scholar
  68. Janier, M., Morel, P. and Civatte, J. (1990) The Koebner phenomenon in AIDS-related Kaposi's sarcoma. J Am Acad Dermatol. 22, 125–126.PubMedGoogle Scholar
  69. Judde, J. G., Lacoste, V., Briere, J., Kassa-Kelembho, E., Clyti, E., Couppie, P., Buchrieser, C., Tulliez, M., Morvan, J. and Gessain, A. (2000) Monoclonality or oligoclonality of human herpesvirus 8 terminal repeat sequences in Kaposi's sarcoma and other diseases. J Natl Cancer Inst. 92, 729–736.PubMedGoogle Scholar
  70. Jung, C. P., Horster, S., Lohse, P., Bogner, J. R., Emmerich, B. and Goebel, F. D. (2003) Uncommon hematologic malignancies. Case 1. Plasmablastic leukemia in HIV-associated multicentric Castleman's disease. J Clin Oncol. 21, 4248–4249.Google Scholar
  71. Kamiyama, K., Kinjo, T., Chinen, K., Iwamasa, T., Uezato, H., Miyagi, J. I., Mori, N. and Yamane, N. (2004) Human herpesvirus 8 (HHV8) sequence variations in HHV8 related tumours in Okinawa, a subtropical island in southern Japan. J Clin Pathol. 57, 529–535.PubMedGoogle Scholar
  72. Kaposi, M. (1872) Idiopathic multiple pigmented sarcoma of the skin. English translation CA 1982; 32, 342–347. 4, 265–273 English translation in CA: A Cancer Journal for Clinicians, New York, 1982; 1, 1342–1347.Google Scholar
  73. Katano, H., Sato, Y., Kurata, T., Mori, S. and Sata, T. (2000) Expression and localization of human herpesvirus 8-encoded proteins in primary effusion lymphoma, Kaposi's sarcoma, and multicentric Castleman's disease. Virology. 269, 335–344.PubMedGoogle Scholar
  74. Kedes, D. H., Lagunoff, M., Renne, R. and Ganem, D. (1997) Identification of the gene encoding the major latency-associated nuclear antigen of the Kaposi's sarcoma-associated herpesvirus. J Clin Invest. 100, 2606–2610.PubMedGoogle Scholar
  75. Kedes, D. H., Operskalski, E., Busch, M., Kohn, R., Flood, J. and Ganem, D. (1996) The seroepidemiology of human herpesvirus 8 (Kaposi's sarcoma-associated herpesvirus): distribution of infection in KS risk groups and evidence for sexual transmission. Nat Med. 2, 918–924.PubMedGoogle Scholar
  76. Kellam, P., Boshoff, C., Whitby, D., Matthews, S., Weiss, R. A. and Talbot, S. J. (1997) Identification of a major latent nuclear antigen, LNA-1, in the human herpesvirus 8 genome. J Hum Virol. 1, 19–29.PubMedGoogle Scholar
  77. Keller, A. R., Hochholzer, L. and Castleman, B. (1972) Hyaline-vascular and plasma-cell types of giant lymph node hyperplasia of the mediastinum and other locations. Cancer. 29, 670–683.PubMedGoogle Scholar
  78. Kessler, E. (1985) Multicentric giant lymph node hyperplasia. A report of seven cases. Cancer. 56, 2446–2451.Google Scholar
  79. Klein, U., Gloghini, A., Gaidano, G., Chadburn, A., Cesarman, E., Dalla-Favera, R. and Carbone, A. (2003) Gene expression profile analysis of AIDS-related primary effusion lymphoma (PEL) suggests a plasmablastic derivation and identifies PEL-specific transcripts. Blood. 101, 4115–4121.PubMedGoogle Scholar
  80. Knowles, D. M., Inghirami, G., Ubriaco, A. and Dalla-Favera, R. (1989) Molecular genetic analysis of three AIDS-associated neoplasms of uncertain lineage demonstrates their B-cell derivation and the possible pathogenetic role of Epstein-Barr virus. Blood. 73, 792–799.PubMedGoogle Scholar
  81. Lacoste, V., Mauclere, P., Dubreuil, G., Lewis, J., Georges-Courbot, M. C. and Gessain, A. (2000) KSHV-like herpesviruses in chimps and gorillas. Nature. 407, 151–152.PubMedGoogle Scholar
  82. Lennette, E. T., Blackbourn, D. J. and Levy, J. A. (1996) Antibodies to human herpesvirus type 8 in the general population and in Kaposi's sarcoma patients. Lancet. 348, 858–861.PubMedGoogle Scholar
  83. Levy, J. A. (1995) A new human herpesvirus: KSHV or HHV8? [comment]. Lancet. 346, 8978.Google Scholar
  84. Levy, J. A. and Ziegler, J. L. (1983) Acquired immunodeficiency syndrome is an opportunistic infection and Kaposi's sarcoma results from secondary immune stimulation. Lancet. 2, 78–81.PubMedGoogle Scholar
  85. Li, C. F., Ye, H., Liu, H., Du, M. Q. and Chuang, S. S. (2006) Fatal HHV-8-associated hemophagocytic syndrome in an HIV-negative immunocompetent patient with plasmablastic variant of multicentric Castleman disease (plasmablastic microlymphoma). Am J Surg Pathol. 30, 123–127.PubMedGoogle Scholar
  86. Lisitsyn, N., Lisitsyn, N. and Wigler, M. (1993) Cloning the differences between two complex genomes. Science. 259, 946–951.PubMedGoogle Scholar
  87. Luppi, M., Barozzi, P., Schulz, T. F., Setti, G., Staskus, K., Trovato, R., Narni, F., Donelli, A., Maiorana, A., Marasca, R., Sandrini, S. and Torelli, G. (2000) Bone marrow failure associated with human herpesvirus 8 infection after transplantation. N Engl J Med. 343, 1378–1385.PubMedGoogle Scholar
  88. Mandel, C., Silberstein, M. and Hennessy, O. (1993) Case report: fatal pulmonary Kaposi's sarcoma and Castleman's disease in a renal transplant recipient. Br J Radiol. 66, 264–265.PubMedGoogle Scholar
  89. Marcelin, A. G., Aaron, L., Mateus, C., Gyan, E., Gorin, I., Viard, J. P., Calvez, V. and Dupin, N. (2003) Rituximab therapy for HIV-associated Castleman disease. Blood. 102, 2786–2788.PubMedGoogle Scholar
  90. Martin, D. F., Kuppermann, B. D., Wolitz, R. A., Palestine, A. G., Li, H. and Robinson, C. A. (1999) Oral ganciclovir for patients with cytomegalovirus retinitis treated with a ganciclovir implant. N Engl J Med. 340, 1063–1070.PubMedGoogle Scholar
  91. Matsushima, A. Y., Strauchen, J. A., Lee, G., Scigliano, E., Hale, E. E., Weisse, M. T., Burstein, D., Kamel, O., Moore, P. S. and Chang, Y. (1999) Posttransplantation plasmacytic proliferations related to Kaposi's sarcoma-associated herpesvirus. Am J Surg Pathol. 23, 1393–1400.PubMedGoogle Scholar
  92. Mendez, J. C. and Paya, C. V. (2000) Kaposi's Sarcoma and Transplantation. Herpes. 7, 18–23.PubMedGoogle Scholar
  93. Miles, S. A., Martinez, M. O., Rezai, A., Magpantay, L., Kishimoto, T., Nakamura, S., Radka, S. F. and Linsley, P. S. (1992) Oncostatin M as a potent mitogen for AIDS-Kaposi's sarcoma-derived cells. Science. 255, 1432–1434.PubMedGoogle Scholar
  94. Miller, G., Rigsby, M. O., Heston, L., Grogan, E., Sun, R., Metroka, C., Levy, J. A., Gao, S. J., Chang, Y. and Moore, P. (1996) Antibodies to butyrate-inducible antigens of Kaposi's sarcoma-associated herpesvirus in patients with HIV-1 infection. New Engl J Med. 334, 1292–1297.PubMedGoogle Scholar
  95. Molden, J., Chang, Y., You, Y., Moore, P. S. and Goldsmith, M. A. (1997) A Kaposi's sarcoma-associated herpesvirus-encoded cytokine homolog (vIL-6) activates signaling through the shared gp130 receptor subunit. J Biol Chem. 272, 19625–19631.PubMedGoogle Scholar
  96. Moore, P. S. (2000) The emergence of Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8). N Engl J Med. 343, 1411–1413.PubMedGoogle Scholar
  97. Moore, P. S., Boshoff, C., Weiss, R. A. and Chang, Y. (1996) Molecular mimicry of human cytokine and cytokine response pathway genes by KSHV. Science. 274, 1739–1744.PubMedGoogle Scholar
  98. Moore, P. S. and Chang, Y. (1995) Detection of herpesvirus-like DNA sequences in Kaposi's sarcoma lesions from persons with and without HIV infection. New Engl J Med. 332, 1181–1185.PubMedGoogle Scholar
  99. Moore, P. S. and Chang, Y. (2001) Molecular virology of Kaposi's sarcoma-associated herpesvirus. Philos Trans R Soc Lond B Biol Sci. 356, 499–516.PubMedGoogle Scholar
  100. Moore, P. S., Gao, S. J., Dominguez, G., Cesarman, E., Lungu, O., Knowles, D. M., Garber, R., Pellett, P. E., McGeoch, D. J. and Chang, Y. (1996) Primary characterization of a herpesvirus agent associated with Kaposi's sarcoma. J Virol. 70, 549–558.PubMedGoogle Scholar
  101. Moore, P. S., Kingsley, L. A., Holmberg, S. D., Spira, T., Gupta, P., Hoover, D. R., Parry, J. P., Conley, L. J., Jaffe, H. W. and Chang, Y. (1996) Kaposi's sarcoma-associated herpesvirus infection prior to onset of Kaposi's sarcoma. AIDS. 10, 175–180.PubMedGoogle Scholar
  102. Murgia, C., Pritchard, J. K., Kim, S. Y., Fassati, A. and Weiss, R. A. (2006) Clonal origin and evolution of a transmissible cancer. Cell. 126, 477–487.PubMedGoogle Scholar
  103. Nador, R. G., Cesarman, E., Chadburn, A., Dawson, D. B., Ansari, M. Q., Sald, J. and Knowles, D. M. (1996) Primary effusion lymphoma: a distinct clinicopathologic entity associated with the Kaposi's sarcoma-associated herpes virus. Blood. 88, 645–656.PubMedGoogle Scholar
  104. Nair, B. C., DeVico, A. L., Nakamura, S., Copeland, T. D., Chen, Y., Patel, A., O'Neil, T., Oroszlan, S., Gallo, R. C. and Sarngadharan, M. G. (1992) Identification of a major growth factor for AIDS-Kaposi's sarcoma cells as oncostatin M. Science. 255, 1430–1432.PubMedGoogle Scholar
  105. Neipel, F., Albrecht, J. C., Ensser, A., Huang, Y. Q., Li, J. J., Friedman, K. A. and Fleckenstein, B. (1997) Human herpesvirus 8 encodes a homolog of interleukin-6. J Virol. 71, 839–842.PubMedGoogle Scholar
  106. Newsom-Davis, T., Bower, M., Wildfire, A., Thirlwell, C., Nelson, M., Gazzard, B. and Stebbing, J. (2004) Resolution of AIDS-related Castleman's disease with anti-CD20 monoclonal antibodies is associated with declining IL-6 and TNF-alpha levels. Leuk Lymphoma. 45, 1939–1941.PubMedGoogle Scholar
  107. Nicholas, J., Ruvolo, V. R., Burns, W. H., Sandford, G., Wan, X., Ciufo, D., Hendrickson, S. B., Guo, H. G., Hayward, G. S. and Reitz, M. S. (1997) Kaposi's sarcoma-associated human herpesvirus-8 encodes homologues of macrophage inflammatory protein-1 and interleukin-6. Nat Med. 3, 287–292.PubMedGoogle Scholar
  108. Nishimoto, N., Kanakura, Y., Aozasa, K., Johkoh, T., Nakamura, M., Nakano, S., Nakano, N., Ikeda, Y., Sasaki, T., Nishioka, K., Hara, M., Taguchi, H., Kimura, Y., Kato, Y., Asaoku, H., Kumagai, S., Kodama, F., Nakahara, H., Hagihara, K., Yoshizaki, K. and Kishimoto, T. (2005) Humanized anti-interleukin-6 receptor antibody treatment of multicentric Castleman disease. Blood. 106, 2627–2632.PubMedGoogle Scholar
  109. Nishimoto, N., Sasai, M., Shima, Y., Nakagawa, M., Matsumoto, T., Shirai, T., Kishimoto, T. and Yoshizaki, K. (2000) Improvement in Castleman's disease by humanized anti-interleukin-6 receptor antibody therapy. Blood. 95, 56–61.PubMedGoogle Scholar
  110. Oksenhendler, E., Boulanger, E., Galicier, L., Du, M. Q., Dupin, N., Diss, T. C., Hamoudi, R., Daniel, M. T., Agbalika, F., Boshoff, C., Clauvel, J. P., Isaacson, P. G. and Meignin, V. (2002) High incidence of Kaposi sarcoma-associated herpesvirus-related non-Hodgkin lymphoma in patients with HIV infection and multicentric Castleman disease. Blood. 99, 2331–2336.PubMedGoogle Scholar
  111. Oksenhendler, E., Carcelain, G., Aoki, Y., Boulanger, E., Maillard, A., Clauvel, J. P. and Agbalika, F. (2000) High levels of human herpesvirus 8 viral load, human interleukin-6, interleukin-10, and C reactive protein correlate with exacerbation of multicentric castleman disease in HIV-infected patients. Blood. 96, 2069–2073.PubMedGoogle Scholar
  112. Oksenhendler, E., Clauvel, J. P., Jouveshomme, S., Davi, F. and Mansour, G. (1998) Complete remission of a primary effusion lymphoma with antiretroviral therapy. Am J Hematol. 57, 266.Google Scholar
  113. Oksenhendler, E., Duarte, M., Soulier, J., Cacoub, P., Welker, Y., Cadranel, J., Cazals, H. D., Autran, B., Clauvel, J. P. and Raphael, M. (1996) Multicentric Castleman's disease in HIV infection: a clinical and pathological study of 20 patients. AIDS. 10, 61–67.PubMedGoogle Scholar
  114. Osborne, J., Moore, P. S. and Chang, Y. (1999) KSHV-encoded viral IL-6 activates multiple human IL-6 signaling pathways. Hum Immunol. 60, 921–927.PubMedGoogle Scholar
  115. Parravicini, C., Chandran, B., Corbellino, M., Berti, E., Paulli, M., Moore, P. S. and Chang, Y. (2000) Differential viral protein expression in Kaposi's sarcoma-associated herpesvirus-infected diseases: Kaposi's sarcoma, primary effusion lymphoma, and multicentric Castleman's disease. Am J Pathol. 156, 743–749.PubMedGoogle Scholar
  116. Parravicini, C., Corbellino, M., Paulli, M., Magrini, U., Lazzarino, M., Moore, P. S. and Chang, Y. (1997) Expression of a virus-derived cytokine, KSHV vIL-6, in HIV-seronegative Castleman's disease. Am J Pathol. 151, 1517–1522.PubMedGoogle Scholar
  117. Parravicini, C., Olsen, S. J., Capra, M., Poli, F., Sirchia, G., Gao, S.-J., Berti, E., Nocera, A., Rossi, E., Bestetti, G., Pizzuto, M., Galli, M., Moroni, M., Moore, P. S. and Corbellino, M. (1997) Risk of Kaposi's sarcoma-associated herpesvirus transmission from donor allografts among Italian posttransplant Kaposi's sarcoma patients. Blood. 90, 2826–2829.PubMedGoogle Scholar
  118. Pellett, P. E., Wright, D. J., Engels, E. A., Ablashi, D. V., Dollard, S. C., Forghani, B., Glynn, S. A., Goedert, J. J., Jenkins, F. J., Lee, T. H., Neipel, F., Todd, D. S., Whitby, D., Nemo, G. J. and Busch, M. P. (2003) Multicenter comparison of serologic assays and estimation of human herpesvirus 8 seroprevalence among US blood donors. Transfusion. 43, 1260–1268.PubMedGoogle Scholar
  119. Penn, I. (1979) Kaposi's sarcoma in organ transplant recipients: report of 20 cases. Transplantation. 27, 8–11.PubMedGoogle Scholar
  120. Platt, G., Carbone, A. and Mittnacht, S. (2002) p16INK4a loss and sensitivity in KSHV associated primary effusion lymphoma. Oncogene. 21, 1823–1831.PubMedGoogle Scholar
  121. Rainbow, L., Platt, G. M., Simpson, G. R., Sarid, R., Gao, S. J., Stoiber, H., Herrington, C. S., Moore, P. S. and Schulz, T. F. (1997) The 222- to 234-kilodalton latent nuclear protein (LNA) of Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8) is encoded by orf73 and is a component of the latency-associated nuclear antigen. J Virol. 71, 5915–5921.PubMedGoogle Scholar
  122. Renne, R., Lagunoff, M., Zhong, W. and Ganem, D. (1996) The size and conformation of Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8) DNA in infected cells and virions. J Virol. 70, 8151–8154.PubMedGoogle Scholar
  123. Renne, R., Zhong, W., Herndier, B., McGrath, M., Abbey, N., Kedes, D. and Ganem, D. (1996) Lytic growth of Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8) in culture. Nat Med. 2, 342–346.PubMedGoogle Scholar
  124. Rose, T. M., Strand, K. B., Schultz, E. R., Schaefer, G., Rankin, G. J., Thouless, M. E., Tsai, C. C. and Bosch, M. L. (1997) Identification of two homologs of the Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8) in retroperitoneal fibromatosis of different macaque species. J Virol. 71, 4138–4144.PubMedGoogle Scholar
  125. Russo, J. J., Bohenzky, R. A., Chien, M. C., Chen, J., Yan, M., Maddalena, D., Parry, J. P., Peruzzi, D., Edelman, I. S., Chang, Y. and Moore, P. S. (1996) Nucleotide sequence of the Kaposi sarcoma-associated herpesvirus (HHV8). Proc Natl Acad Sci U S A. 93, 14862–14867.Google Scholar
  126. Rywlin, A. M., Rosen, L. and Cabello, B. (1983) Coexistence of Castleman's disease and Kaposi's sarcoma. Report of a case and a speculation. Am J Dermatopathol. 5, 277–281.Google Scholar
  127. Sarid, R., Olsen, S. J. and Moore, P. S. (1999) Kaposi's sarcoma-associated herpesvirus: epidemiology, virology and molecular biology. Adv Virus Res. 52, 139–232.PubMedGoogle Scholar
  128. Schalling, M., Ekman, M., Kaaya, E. E., Linde, A. and Biberfeld, P. (1995) A role for a new herpesvirus (KSHV) in different forms of Kaposi's sarcoma. Nat Med. 1, 707–708.PubMedGoogle Scholar
  129. Seckin, D., Ozcan, G., Demirag, A., Hizel, N. and Haberal, M. (1998) The Koebner phenomenon in Kaposi's sarcoma in a renal transplant recipient [letter]. Br J Dermatol. 139, 346–348.PubMedGoogle Scholar
  130. Simpson, G. R., Schulz, T. F., Whitby, D., Cook, P. M., Boshoff, C., Rainbow, L., Howard, M. R., Gao, S. J., Bohenzky, R. A., Simmonds, P., Lee, C., de Ruiter, A., Hatzakis, A., Tedder, R. S., Weller, I. V., Weiss, R. A. and Moore, P. S. (1996) Prevalence of Kaposi's sarcoma associated herpesvirus infection measured by antibodies to recombinant capsid protein and latent immunofluorescence antigen. Lancet. 348, 1133–1138.PubMedGoogle Scholar
  131. Soulier, J., Grollet, L., Oksenhendler, E., Cacoub, P., Cazals-Hatem, D., Babinet, P., d'Agay, M.-F., Clauvel, J.-P., Raphael, M., Degos, L. and Sigaux, F. (1995) Kaposi's sarcoma-associated herpesvirus-like DNA sequences in multicentric Castleman's disease. Blood. 86, 1276–1280.PubMedGoogle Scholar
  132. Strauchen, J. A., Hauser, A. D., Burstein, D. A., Jiminez, R., Moore, P. S. and Chang, Y. (1996) Body cavity-based malignant lymphoma containing Kaposi sarcoma-associated herpesvirus in an HIV-negative man with previous Kaposi Sarcoma. Ann Intern Med. 125, 822–825.PubMedGoogle Scholar
  133. Su, I.-J., Hsu, Y.-S., Chang, Y.-C. and Wang, I.-W. (1995) Herpesvirus-like DNA sequence in Kaposi's sarcoma from AIDS and non-AIDS patients in Taiwan. Lancet. 345, 722–723.PubMedGoogle Scholar
  134. Wabinga, H. R., Parkin, D. M., Wabwire-Mangen, F. and Mugerwa, J. (1993) Cancer in Kampala, Uganda, in 1989–91: changes in incidence in the era of AIDS. Int J Cancer. 54, 5–22.Google Scholar
  135. Wabinga, H. R., Parkin, D. M., Wabwire-Mangen, F. and Mugerwa, J. W. (1993) Cancer in Kampala, Uganda, in 1989–91: changes in incidence in the era of AIDS. Int J Cancer. 54, 26–36.PubMedGoogle Scholar
  136. Walter, P. R., Philippe, E., Nguemby-Mbina, C. and Chamlian, A. (1984) Kaposi's sarcoma: presence of herpes-type particles in a tumor specimen. Hum Pathol. 15, 1145–1146.PubMedGoogle Scholar
  137. Whitby, D., Howard, M. R., Tenant-Flowers, M., Brink, N. S., Copas, A., Boshoff, C., Hatziouannou, T., Suggett, F. E. A., Aldam, D. M., Denton, A. S., Miller, R. F., Weller, I. V. D., Weiss, R. A., Tedder, R. S. and Schulz, T. F. (1995) Detection of Kaposi's sarcoma-associated herpesvirus (KSHV) in peripheral blood of HIV-infected individuals predicts progression to Kaposi's sarcoma. Lancet. 364, 799–802.Google Scholar
  138. Wilson, K. S., McKenna, R. W., Kroft, S. H., Dawson, D. B., Ansari, Q. and Schneider, N. R. (2002) Primary effusion lymphomas exhibit complex and recurrent cytogenetic abnormalities. Br J Haematol. 116, 113–121.PubMedGoogle Scholar
  139. Wood, R. D., Robins, P. and Lindahl, T. (1988) Complementation of the xeroderma pigmentosum DNA repair defect in cell-free extracts. Cell. 53, 97–106.PubMedGoogle Scholar
  140. Yoshizaki, K., Matsuda, T., Nishimoto, N., Kuritani, T., Taeho, L., Aozasa, K., Nakahata, T., Kawai, H., Tagoh, H., Komori, T., Kishimoto, S., Hirano, T. and Kishimoto, T. (1989) Pathogenic significance of interleukin-6 (IL-6/BSF-2) in Castleman's disease. Blood. 74, 1360–1367.PubMedGoogle Scholar
  141. Zhong, W., Wang, H., Herndier, B. and Ganem, D. (1996) Restricted expression of Kaposi sarcoma-associated herpesvirus (human herpesvirus 8) genes in Kaposi sarcoma. Proc Natl Acad Sci U S A. 93, 6641–6646.Google Scholar
  142. Ziegler, J. L. and Katongole-Mbidde, E. (1996) Kaposi's sarcoma in childhood: an analysis of 100 cases from Uganda and relationship to HIV infection. Int J Cancer. 65, 200–203.PubMedGoogle Scholar
  143. Zong, J., Ciufo, D. M., Viscidi, R., Alagiozoglou, L., Tyring, S., Rady, P., Orenstein, J., Boto, W., Kalumbuja, H., Romano, N., Melbye, M., Kang, G. H., Boshoff, C. and Hayward, G. S. (2002) Genotypic analysis at multiple loci across Kaposi's sarcoma herpesvirus (KSHV) DNA molecules: clustering patterns, novel variants and chimerism. J Clin Virol. 23, 119–148.PubMedGoogle Scholar

Copyright information

© Springer Science + Business Media, LLC 2009

Authors and Affiliations

  1. 1.Molecular Virology ProgramUniversity of Pittsburgh Cancer InstitutePittsburghUSA
  2. 2.Molecular Virology ProgramUniversity of Pittsburgh Cancer InstitutePittsburghUSA

Personalised recommendations